254 related articles for article (PubMed ID: 23118425)
1. Interferon-γ and tumor necrosis factor-α sustain secretion of specific CXC chemokines in human thyrocytes: a first step toward a differentiation between autoimmune and tumor-related inflammation?
Rotondi M; Coperchini F; Pignatti P; Sideri R; Groppelli G; Leporati P; La Manna L; Magri F; Mariotti S; Chiovato L
J Clin Endocrinol Metab; 2013 Jan; 98(1):308-13. PubMed ID: 23118425
[TBL] [Abstract][Full Text] [Related]
2. Differential modulation of CXCL8 versus CXCL10, by cytokines, PPAR-gamma, or PPAR-alpha agonists, in primary cells from Graves' disease and ophthalmopathy.
Ferrari SM; Ragusa F; Paparo SR; Nasini F; Nardi M; Franceschini SS; Fallahi P; Antonelli A
Autoimmun Rev; 2019 Jul; 18(7):673-678. PubMed ID: 31059842
[TBL] [Abstract][Full Text] [Related]
3. Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists.
Antonelli A; Rotondi M; Ferrari SM; Fallahi P; Romagnani P; Franceschini SS; Serio M; Ferrannini E
J Clin Endocrinol Metab; 2006 Feb; 91(2):614-20. PubMed ID: 16303841
[TBL] [Abstract][Full Text] [Related]
4. Monokine induced by interferon gamma (IFNgamma) (CXCL9) and IFNgamma inducible T-cell alpha-chemoattractant (CXCL11) involvement in Graves' disease and ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists.
Antonelli A; Ferrari SM; Fallahi P; Frascerra S; Santini E; Franceschini SS; Ferrannini E
J Clin Endocrinol Metab; 2009 May; 94(5):1803-9. PubMed ID: 19276231
[TBL] [Abstract][Full Text] [Related]
5. Effect of Interferon-γ on the Basal and the TNFα-Stimulated Secretion of CXCL8 in Thyroid Cancer Cell Lines Bearing Either the RET/PTC Rearrangement Or the BRAF V600e Mutation.
Rotondi M; Coperchini F; Awwad O; Pignatti P; Di Buduo CA; Abbonante V; Magri F; Balduini A; Chiovato L
Mediators Inflamm; 2016; 2016():8512417. PubMed ID: 27555670
[TBL] [Abstract][Full Text] [Related]
6. Type I and type II interferons inhibit both basal and tumor necrosis factor-α-induced CXCL8 secretion in primary cultures of human thyrocytes.
Rotondi M; Coperchini F; Sideri R; Groppelli G; de Martinis L; Villani L; Pignatti P; Magri F; Chiovato L
J Interferon Cytokine Res; 2013 Sep; 33(9):508-13. PubMed ID: 23675779
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor α agonists modulate Th1 and Th2 chemokine secretion in normal thyrocytes and Graves' disease.
Antonelli A; Ferrari SM; Frascerra S; Corrado A; Pupilli C; Bernini G; Benvenga S; Ferrannini E; Fallahi P
Exp Cell Res; 2011 Jul; 317(11):1527-33. PubMed ID: 21565188
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of secretion of CXC alpha-chemokine CXCL10 in papillary thyroid cancer: modulation by peroxisome proliferator-activated receptor-gamma agonists.
Antonelli A; Ferrari SM; Fallahi P; Frascerra S; Piaggi S; Gelmini S; Lupi C; Minuto M; Berti P; Benvenga S; Basolo F; Orlando C; Miccoli P
Endocr Relat Cancer; 2009 Dec; 16(4):1299-311. PubMed ID: 19755523
[TBL] [Abstract][Full Text] [Related]
9. Cytokines (interferon-γ and tumor necrosis factor-α)-induced nuclear factor-κB activation and chemokine (C-X-C motif) ligand 10 release in Graves disease and ophthalmopathy are modulated by pioglitazone.
Antonelli A; Ferrari SM; Fallahi P; Piaggi S; Paolicchi A; Franceschini SS; Salvi M; Ferrannini E
Metabolism; 2011 Feb; 60(2):277-83. PubMed ID: 20206950
[TBL] [Abstract][Full Text] [Related]
10. Methimazole inhibits CXC chemokine ligand 10 secretion in human thyrocytes.
Crescioli C; Cosmi L; Borgogni E; Santarlasci V; Gelmini S; Sottili M; Sarchielli E; Mazzinghi B; Francalanci M; Pezzatini A; Perigli G; Vannelli GB; Annunziato F; Serio M
J Endocrinol; 2007 Oct; 195(1):145-55. PubMed ID: 17911406
[TBL] [Abstract][Full Text] [Related]
11. Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies.
Proost P; Struyf S; Loos T; Gouwy M; Schutyser E; Conings R; Ronsse I; Parmentier M; Grillet B; Opdenakker G; Balzarini J; Van Damme J
Arthritis Res Ther; 2006; 8(4):R107. PubMed ID: 16846531
[TBL] [Abstract][Full Text] [Related]
12. Elocalcitol inhibits inflammatory responses in human thyroid cells and T cells.
Borgogni E; Sarchielli E; Sottili M; Santarlasci V; Cosmi L; Gelmini S; Lombardi A; Cantini G; Perigli G; Luconi M; Vannelli GB; Annunziato F; Adorini L; Serio M; Crescioli C
Endocrinology; 2008 Jul; 149(7):3626-34. PubMed ID: 18372324
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum interferon-gamma-inducible chemokine-10/CXC chemokine ligand-10 in autoimmune primary adrenal insufficiency and in vitro expression in human adrenal cells primary cultures after stimulation with proinflammatory cytokines.
Rotondi M; Falorni A; De Bellis A; Laureti S; Ferruzzi P; Romagnani P; Buonamano A; Lazzeri E; Crescioli C; Mannelli M; Santeusanio F; Bellastella A; Serio M
J Clin Endocrinol Metab; 2005 Apr; 90(4):2357-63. PubMed ID: 15657375
[TBL] [Abstract][Full Text] [Related]
14. Metformin reverts the secretion of CXCL8 induced by TNF-α in primary cultures of human thyroid cells: an additional indirect anti-tumor effect of the drug.
Rotondi M; Coperchini F; Pignatti P; Magri F; Chiovato L
J Clin Endocrinol Metab; 2015 Mar; 100(3):E427-32. PubMed ID: 25590211
[TBL] [Abstract][Full Text] [Related]
15. Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-10 and Mig and attract CXCR3+ lymphocytes.
García-López MA; Sancho D; Sánchez-Madrid F; Marazuela M
J Clin Endocrinol Metab; 2001 Oct; 86(10):5008-16. PubMed ID: 11600578
[TBL] [Abstract][Full Text] [Related]
16. Interferon-alpha, -beta and -gamma induce CXCL9 and CXCL10 secretion by human thyrocytes: modulation by peroxisome proliferator-activated receptor-gamma agonists.
Antonelli A; Ferrari SM; Fallahi P; Ghiri E; Crescioli C; Romagnani P; Vitti P; Serio M; Ferrannini E
Cytokine; 2010 Jun; 50(3):260-7. PubMed ID: 20299237
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation by IFN‑γ on TNF‑α‑induced chemokine expression in synovial fibroblasts from temporomandibular joint.
Ohta K; Naruse T; Kato H; Ishida Y; Nakagawa T; Ono S; Shigeishi H; Takechi M
Mol Med Rep; 2017 Nov; 16(5):6850-6857. PubMed ID: 28901435
[TBL] [Abstract][Full Text] [Related]
18. Normal human thyroid cells, BCPAP, and TPC-1 thyroid tumor cell lines display different profile in both basal and TNF-α-induced CXCL8 secretion.
Coperchini F; Pignatti P; Leporati P; Carbone A; Croce L; Magri F; Chiovato L; Rotondi M
Endocrine; 2016 Oct; 54(1):123-128. PubMed ID: 26450713
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms underlying the pro-inflammatory synergistic effect of tumor necrosis factor alpha and interferon gamma in human microvascular endothelium.
Lombardi A; Cantini G; Mello T; Francalanci M; Gelmini S; Cosmi L; Santarlasci V; Degl'Innocenti S; Luciani P; Deledda C; Annunziato F; Forti G; Galli A; Serio M; Luconi M
Eur J Cell Biol; 2009 Dec; 88(12):731-42. PubMed ID: 19782427
[TBL] [Abstract][Full Text] [Related]
20. Cytokines differentially regulate CXCL10 production by interferon-gamma-stimulated or tumor necrosis factor-alpha-stimulated human gingival fibroblasts.
Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
J Periodontal Res; 2009 Apr; 44(2):225-31. PubMed ID: 18973545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]